- Home
- ENTX vs NAUT Comparison
ENTX vs NAUT Comparison
Compare ENTX & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- NAUT
- Stock Information
- Founded
- ENTX 2010
- NAUT 2016
- Country
- ENTX Israel
- NAUT United States
- Employees
- ENTX N/A
- NAUT N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- ENTX Health Care
- NAUT Industrials
- Exchange
- ENTX Nasdaq
- NAUT Nasdaq
- Market Cap
- ENTX 86.3M
- NAUT 95.6M
- IPO Year
- ENTX 2018
- NAUT N/A
- Fundamental
- Price
- ENTX $2.01
- NAUT $0.68
- Analyst Decision
- ENTX Strong Buy
- NAUT Strong Sell
- Analyst Count
- ENTX 1
- NAUT 1
- Target Price
- ENTX $10.00
- NAUT $1.75
- AVG Volume (30 Days)
- ENTX 66.0K
- NAUT 192.3K
- Earning Date
- ENTX 11-07-2025
- NAUT 10-28-2025
- Dividend Yield
- ENTX N/A
- NAUT N/A
- EPS Growth
- ENTX N/A
- NAUT N/A
- EPS
- ENTX N/A
- NAUT N/A
- Revenue
- ENTX $166,000.00
- NAUT N/A
- Revenue This Year
- ENTX N/A
- NAUT N/A
- Revenue Next Year
- ENTX N/A
- NAUT N/A
- P/E Ratio
- ENTX N/A
- NAUT N/A
- Revenue Growth
- ENTX 191.23
- NAUT N/A
- 52 Week Low
- ENTX $1.50
- NAUT $0.62
- 52 Week High
- ENTX $2.79
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- ENTX 52.55
- NAUT 44.48
- Support Level
- ENTX $2.00
- NAUT $0.62
- Resistance Level
- ENTX $2.22
- NAUT $0.73
- Average True Range (ATR)
- ENTX 0.11
- NAUT 0.04
- MACD
- ENTX 0.01
- NAUT -0.00
- Stochastic Oscillator
- ENTX 50.00
- NAUT 51.43
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.